Symptomatic Relief of Skin Toxicities Induced by EGFR TKI Therapy: Use of Bicarbonate Ion Bath Salts
Year: 2025
Type: article
Abstract: Introduction: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy for non–small cell lung cancer with EGFR gene mutation is associated with a high occurrence of skin disorders, such as dermatitis, dry skin, and paronychia. Moisturizers, steroids, and oral minocycline are used to treat these adverse effects, with limited efficacy. We conducted a pilot study to investigate the usefulness of bicarbonate ion bath salts, which are known to have excellent moisturizing properties, for treating skin disorders caused by EGFR TKI therapy.
DOI: 10.4993/acrt.33.5
Authors: Mitsuhiro Kamimura, Tatsuya Ibe, Atsuto Mouri
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4407479389
